Ebola epidemic, the endangered disease spread tension worldwide may have an end soon, hoping the World Health Organisation.
On Wednesday, the World Health Organization (WHO) coordinated clinical trials of an experimental vaccine against the killer virus, which sparked a deadly riot in Sierra Leone
Almost 1,600 doses of the vaccine arrived in Geneva which the WHO, under fire for what has been seen as a lethargic response to the outbreak, hopes can be fast-tracked into "real-world use".
At the same time, doctors said today two people died in a riot the day before in eastern Sierra Leone, which erupted when health workers tried to take a blood sample from a 90-year-old woman suspected of having Ebola.
Meanwhile, several buildings were attacked and gangs of youths roamed the streets shouting "No more Ebola!"
Not only Sierra Leone, but also other neighbouring places such as Guinea and Liberia are the epicentre of the Ebola outbreak, which has killed more than 4,500 people including a handful outside the region, the world's worst ever epidemic death rate.
Health experts were warning that the rate of infections could reach 10,000 a week by early December, so the health teams are working desperately to slow the alarming spread of the virus.
The WHO launched a new emergency consultations, which connecting policymakers and health experts in Geneva and on the ground in west Africa by video and phone.
Since the WHO declared the outbreak an international crisis in August, the third talk will likely last two days, with a news conference planned the day after they wrap up.
On Wednesday, Some 1,600 doses of the experimental rVSV vaccine against Ebola arrived at the Geneva University Hospital from Canada.
The WHO plans to coordinate trials of the vaccine in Geneva alongside those already under way in Germany, Gabon and Kenya.
The vaccine was developed at the National Microbiology Laboratory in Winnipeg, is one of two experimental Ebola vaccines identified by the WHO as having shown promising results when tested on monkeys.
Marie-Paule Kieny, the assistant director general said on Tuesday that the goal was to be able to ship initial supplies to Africa by early 2015, though mass vaccination campaigns are not yet on the cards.
She said, "There is a very strong movement now from governments of many countries to push as quickly as possible these vaccines into real-world use."